tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
SYRE
Spyre Therapeutics
RESEARCH TOOLSreports
Want to see SYRE full AI Analyst Report?

Spyre Therapeutics (SYRE) Stock News & Sentiment

553 Followers
Julian Harrison Reiterates Buy on Spyre Therapeutics, Maintains $98 Price Target on Strong IBD Pipeline and Cash Runway
Premium
Ratings
Julian Harrison Reiterates Buy on Spyre Therapeutics, Maintains $98 Price Target on Strong IBD Pipeline and Cash Runway
3d ago
SYRE
Spyre Therapeutics’ Exclusive Forum Clauses Shift Legal Leverage, Raise Venue and Litigation Cost Concerns for Stockholders
Premium
Company Announcements
Spyre Therapeutics’ Exclusive Forum Clauses Shift Legal Leverage, Raise Venue and Litigation Cost Concerns for Stockholders
3d ago
SYRE
Spyre Therapeutics: Buy Rating Reaffirmed as External Combo Data Support IBD Strategy; $95 Price Target Unchanged
Premium
Ratings
Spyre Therapeutics: Buy Rating Reaffirmed as External Combo Data Support IBD Strategy; $95 Price Target Unchanged
10d ago
SYRE
Spyre Therapeutics Raises Capital Through Completed Stock Offering
Premium
Company Announcements
Spyre Therapeutics Raises Capital Through Completed Stock Offering
23d ago
8K
SYRE
3 Best Trending Stocks, According to Analysts – 4/16/2026
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/16/2026
23d ago
AMZN
GSAT
Spyre Therapeutics Pauses At-The-Market Equity Offering Program
Premium
Company Announcements
Spyre Therapeutics Pauses At-The-Market Equity Offering Program
26d ago
8K
SYRE
Buy Rating on SYRE: Early SPY001 Outperformance, Broad IBD Opportunity, and Catalyst‑Rich Path Support Higher $80 Target
Premium
Ratings
Buy Rating on SYRE: Early SPY001 Outperformance, Broad IBD Opportunity, and Catalyst‑Rich Path Support Higher $80 Target
26d ago
SYRE
More SYRE News >

SYRE News on the Web

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE) and Revolution Medicines (RVMD)
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), Spyre Therapeutics (SYRE)
TipRanks News
Neutral
Spyre Therapeutics price target raised to $95 from $64 at JonesResearch
TipRanks News
Bullish
Spyre Therapeutics Raises Capital Through Completed Stock Offering
TipRanks News
Neutral
3 Best Trending Stocks, According to Analysts – 4/16/2026
TipRanks News
Bullish
Why Spyre Therapeutics Shares Are Surging Higher
TipRanks News
Bullish
Spyre Therapeutics 6.5M share Secondary priced at $62.00
TipRanks News
Bullish
Spyre Therapeutics Secures $403 Million in Upsized Public Offering—Major Capital Boost Signals Confidence in IBD Drug Pipeline
Market Chameleon
Bullish

News Score - Last 7 Days

Very Positive
SYRE
Sector Average
Media Buzz
This Week15 articles
Weekly Average11.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SYRE’s Media Buzz Sentiment?
15 articles about SYRE were published this week. In an average week, 11.5 articles are published.
    What is SYRE’s weekly average amount of articles?
    In an average week, 11.5 articles about SYRE are published.
      What is SYRE’s News Sentiment?
      100% of articles about SYRE were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week